Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19

Official Title

Brief Summary

The aim of this possible study is to identify if SARS-CoV-2 can be found in the tear film and conjunctiva of a patient with COVID-19.

Status

Unknown status

Conditions

COVID-19

SARS-CoV 2

Interventions

Diagnostic Test: Conjunctival swab and nasopharyngeal swab

Both conjunctival swab and nasopharyngeal swab for SARS-COV 2 are conducted in patients with COVID-19.

Eligibility Criteria

Inclusion Criteria:

- Age ≥ 18 years

- A confirmed COVID-19 disease

- Signed and dated declaration of consent

- The patient fell ill in Tyrol

Exclusion Criteria:

- none

Eligibility Gender

All

Eligibility Age

Minimum: 18 Years ~ Maximum: N/A

Countries

Austria

Locations

Medical University Innsbruck
Innsbruck, Tirol, Austria

Investigator: Teresa Rauchegger, Dr.
Contact: 0043 504 24184
teresa.rauchegger@i-med.ac.at

NCT Number

NCT04444596

MeSH Terms

COVID-19

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

Medical University Innsbruck

Conjunctival Swab vs Nasopharyngeal Swab in Patients With COVID-19

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA